Cardiovascular Intervention and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.5 | Q1 | 81.4% | 0.654 | Q2 | 70.6% |
| 2024 | 5.8 | Q1 | 85.2% | 0.834 | Q1 | 79.2% |
| 2023 | 3.1 | Q2 | 72.6% | 0.822 | Q1 | 80.6% |
| 2022 | 3.2 | 69.1% | 0.832 | Q1 | 81.6% | |
| 2021 | — | 39.6% | 0.874 | Q1 | 83.5% | |
| 2020 | — | — | 0.524 | Q3 | 67.6% | |
| 2019 | — | — | 0.442 | Q3 | 63.8% | |
| 2018 | — | — | 0.368 | Q3 | 56.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1868-4300
ISSN
1868-4297
region
Asiatic Region
coverage
2010-2026